Roche OTC sales
This article was originally published in The Tan Sheet
Executive Summary
First quarter revenues were up 5% in local currencies to $328 mil., Swiss firm announces April 21. Excluding Chugai OTCs in Japan, sales were ahead 8% in local currencies, outpacing the market, Roche added. The increase was driven by solid growth in core markets Spain, the UK, Brazil and Turkey. A decision on the divestiture of the Consumer Health group is expected in the second half, the firm said. Roche could have a buyer for the business by early summer (1"The Tan Sheet" March 22, 2004, p. 7)...